The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News | Getty Images Swiss pharmaceutical firm Roche is targeting becoming a top three obesity player globally, posing a potential rival to heavyweights Novo Nordisk and Eli Lilly as it advances one of its experimental weight-loss drugs to…
A proposed vote by Massachusetts Institute of Technology professor Retsef Levi is displayed during an Advisory Committee on Immunization Practices (ACIP) meeting at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S., Sept. 19, 2025. Alyssa Pointer | Reuters New recommendations last week from an influential vaccine panel handpicked by Health and…
Members of the Advisory Committee on Immunization Practices (ACIP) listen to a presentation about COVID-19 (coronavirus disease) during an Advisory Committee on Immunization Practices (ACIP) meeting at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S., Sept. 19, 2025. Alyssa Pointer | Reuters Health and Human Services Secretary Robert F. Kennedy Jr.’s…
Don’t count out Eli Lilly’s oral GLP-1 drug for obesity and diabetes just yet, according to CNBC’s Jim Cramer . That was his takeaway following the latest study involving Lilly’s orforglipron, the experimental pill that has been the subject of Wall Street debate since weight-loss data released in early August came in below investor expectations….
U.S. Health and Human Services Secretary Robert F. Kennedy Jr., testifies before a Senate Finance Committee hearing on President Donald Trump’s 2026 health care agenda, on Capitol Hill in Washington, D.C., U.S., September 4, 2025. Jonathan Ernst | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest…
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Wednesday said its experimental pill outperformed Novo Nordisk‘s own oral drug in the first head-to-head study comparing the two medicines in patients with Type 2 diabetes. The…
Dave Ricks, chair and chief executive officer of Eli Lilly and Company speaks to the Economic Club of New York in New York City, U.S., March 12, 2024. Mike Segar | Reuters U.S. policymakers should take note as biopharmaceutical companies pull back on investments in the U.K., Eli Lilly Chief Executive Officer Dave Ricks said…
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy is seen outside theri building as the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk on Wednesday flagged promising late-stage…
An estimated 4 million Americans will lose health insurance over the next decade if Congress doesn’t extend enhanced subsidies for Affordable Care Act marketplace coverage, which expire at the end of the year. Miami Herald | Tribune News Service | Getty Images Leighanne Safford and her husband, Lorry, pay just $278 a month for health…
U.S. Senate Minority Leader Chuck Schumer (D-NY) speaks to reporters as Senate Democratic leaders hold a press conference following their weekly policy lunch on Capitol Hill in Washington, D.C., U.S., Sept. 9, 2025. Elizabeth Frantz | Reuters Congressional Democrats are zeroing in on health care as a key sticking point in negotiations with the threat…
